Biography
Homer Sun is the Chief Investment Officer of Morgan Stanley Private Equity Asia, a Managing Director of Morgan Stanley and Co-Head of the Fund’s China Investment Operations. Mr. Sun also serves on the Firm’s China Management Committee, which is comprised of the Firm’s senior business leaders within China. 

Mr. Sun has spent 18 years at Morgan Stanley and 20 years in Asia. Mr. Sun has led MSPE Asia’s private equity transactions in China for three funds to date: the $525 million Asia Fund II (2005), the $1.5 billion Asia Fund III (2007) and the current $1.7 billion Asia Fund IV. Mr. Sun currently serves as a Director on the boards of Sihuan Pharmaceutical, Renfang Medical, Tianhe Chemicals, China XD Plastics, Noah Education and Nature Home; he was previously a director of Shanshui Cement. Prior to joining Morgan Stanley, Mr. Sun was a mergers and acquisitions lawyer with the law firm Simpson Thacher & Bartlett in New York and Hong Kong. Mr. Sun is Chinese and is based in Hong Kong.  

Mr. Sun received a B.S.E. in chemical engineering, magna cum laude, from the University of Michigan and a J.D., cum laude, from the University of Michigan Law School.
 
Homer is a member of the
Morgan Stanley Private Equity Asia Team
 

Team members may change from time to time.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.

 

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Not FDIC Insured—Offer No Bank Guarantee—May Lose Value
Not Insured By Any Federal Government Agency—Not A Deposit

Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.

Morgan Stanley Distribution, Inc. Member FINRA/SIPC.